{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-010081","form_type":"8-K","ticker":"CRSP","cik":"0001674416","company_name":"CRISPR Therapeutics AG","filed_at":"2022-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.743625+00:00","generated_at":"2026-06-25T15:02:26.812084+00:00","sec_items":["7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CRISPR Therapeutics appoints Phuong Khanh Morrow, M.D., as Chief Medical Officer effective May 23, 2022","bullets":["Dr. Morrow brings over a decade of global drug development experience, most recently as VP at Amgen leading hematology/oncology.","She will lead CRISPR Therapeutics' global clinical development and regulatory operations.","CEO Samarth Kulkarni cited her expertise in oncology and track record in bringing novel medicines to patients."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-010081","json":"https://secwatch.observer/filing/0000950170-22-010081.json","markdown":"https://secwatch.observer/filing/0000950170-22-010081.md","text":"https://secwatch.observer/filing/0000950170-22-010081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674416/000095017022010081/0000950170-22-010081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674416/000095017022010081/crsp-20220516.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T15:02:26.812084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}